Psychometric validation of a constipation symptom assessment questionnaire.
about
Biofeedback for treatment of chronic idiopathic constipation in adultsPatient considerations in the management of chronic constipation: focus on prucaloprideEvolving paradigms in the treatment of opioid-induced bowel dysfunctionConsensus Recommendations on Initiating Prescription Therapies for Opioid-Induced ConstipationA self administered reliable questionnaire to assess lower bowel symptoms.Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart reviewBloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation.Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation.Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.Stapled transanal rectal resection for obstructed defecation syndrome associated with rectocele and rectal intussusception.Prucalopride for constipation.Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipationFive-item score for obstructed defecation syndrome: study of validation.Does the presence of a high grade internal rectal prolapse affect the outcome of pelvic floor retraining in patients with faecal incontinence or obstructed defaecation?Effect of Prucalopride in the Treatment of Chronic Constipation in Asian and Non-Asian Women: A Pooled Analysis of 4 Randomized, Placebo-controlled Studies.Impact of slow transit constipation on the outcome of laparoscopic ventral rectopexy for obstructed defaecation associated with high grade internal rectal prolapse.Transcutaneous Neuromodulation at Posterior Tibial Nerve and ST36 for Chronic ConstipationLubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.Effect of prucalopride on symptoms of chronic constipation.Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation.Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.A prospective trial of temporary sacral nerve stimulation for constipation associated with neurological disease.Cost-effectiveness of prucalopride in the treatment of chronic constipation in the NetherlandsA randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.Development and psychometric characteristics of the SCI-QOL Bladder Management Difficulties and Bowel Management Difficulties item banks and short forms and the SCI-QOL Bladder Complications scale.CON-COUR study: Interferential therapy in the treatment of chronic constipation in adults: study protocol for a randomized controlled trial.Chronic constipation: new diagnostic and treatment approachesEfficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate responseChronic constipation diagnosis and treatment evaluation: the "CHRO.CO.DI.T.E." study.Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study.Controlling anal incontinence in women by performing anal exercises with biofeedback or loperamide (CAPABLe) trial: Design and methods.The Impact of Opioid Treatment on Regional Gastrointestinal Transit.Patient-reported outcomes in gastroenterology: clinical and research applications.Opioid-Induced Constipation among a Convenience Sample of Patients with Cancer Pain.Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndromeEfficacy of Synbiotics in Patients with Slow Transit Constipation: A Prospective Randomized TrialCan wheat germ have a beneficial effect on human health? A study protocol for a randomised crossover controlled trial to evaluate its health effects.
P2860
Q24197862-A3492A65-AC95-409B-81C5-A6480EAC1260Q26741304-B8D1A4DB-E8D9-4497-8A4A-4B196628959CQ26777692-60DB988D-A202-47B9-8695-1DC7089CC62DQ26830397-AC810A3F-4CEE-48E4-8C30-24C02C5A2295Q33321975-1A7D8B9C-2BB0-4279-8981-3F624A8D2BD9Q33461841-7C49B53C-F834-40DB-A787-49189D9CC225Q33467190-383C773E-6FB0-45C5-ADBC-1647B739C264Q33695627-1BC30188-DA13-4A1E-A369-CF6E7BF8F312Q33697904-0C78794D-0BC9-4731-AF76-ADA339756DA9Q33879470-BC620A91-96CF-4F3D-B9FE-332580D8923AQ34094831-35782FA0-A257-4992-94DD-E642BA6E58F6Q34146166-0ED65967-8250-444A-AD0A-712D8195FFA5Q34275782-C2431BDC-A83E-47A8-91E1-31CF67779D2CQ34360102-FC10326E-939F-4790-A2E6-5C0CB81A4862Q34377144-6D6CB936-1187-4C7F-A26F-B6CD90F7DBA4Q34377641-26EC07A0-8D22-45CD-A1B2-743DF336F4FAQ34546572-7C4945DF-659C-4102-A7BD-0F41EB66A064Q34552212-7EDAE889-B9D7-406C-9B42-29C50DA2AC5EQ34638259-D38AE6FC-DB43-42D4-99F2-69C7EA5A5C56Q34764154-B0CE0711-1E5C-4B62-AD9A-85437047DCE2Q34806109-69B42AA2-BF58-46B8-BC01-FC8A5D9B58F8Q35026383-B574C791-E56F-4CCB-80EE-75B1FBA2089BQ35028902-35F92982-0557-4DD1-AEE6-F327D55668FDQ35059682-8CED3E79-3430-4CF9-A53D-B6E1FCFA138BQ35274333-773811E0-74E1-41F1-9A48-F8AF459EDF0FQ35407243-77796E32-AA11-49C4-AD47-4765A44F5B17Q35583251-D34BBF2F-7EF7-499C-B8B3-039B7EE8B19EQ35651164-D14EF092-53B7-41FC-BFEF-CBE858A85494Q35802289-3FACC888-6EC9-4EF7-B6F2-02132CA820BFQ36072686-D1DE49FD-E539-41BD-9B4B-8F254CBC80D6Q36223541-1ABAC05E-3BF9-4218-9F85-DB3147AD5D13Q36249784-D7B8E4FD-909B-4E83-85D3-D4BBBA8FB121Q36431809-76F4C430-DF82-4263-9CDC-4A8776D4A075Q36590611-5F558499-0C45-4E18-99EE-53852E8249D6Q36762661-B2C24A7E-457A-4167-9112-09050C114D61Q36817391-FB7D257F-EB6C-4554-8A60-DD78811B5DC7Q36978683-7C991B81-6AF8-4ACB-93D0-A9D26C7CA8A5Q37206858-70E6F2C3-FD5C-40E8-84C8-6602CAEDD95BQ37373827-B3F1D421-51A7-45CB-A002-82CC26E0A339Q37454817-85746517-A044-4A24-BC89-D1D3FEF3AF0B
P2860
Psychometric validation of a constipation symptom assessment questionnaire.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Psychometric validation of a constipation symptom assessment questionnaire.
@ast
Psychometric validation of a constipation symptom assessment questionnaire.
@en
type
label
Psychometric validation of a constipation symptom assessment questionnaire.
@ast
Psychometric validation of a constipation symptom assessment questionnaire.
@en
prefLabel
Psychometric validation of a constipation symptom assessment questionnaire.
@ast
Psychometric validation of a constipation symptom assessment questionnaire.
@en
P2093
P2860
P1476
Psychometric validation of a constipation symptom assessment questionnaire.
@en
P2093
P2860
P304
P356
10.1080/003655299750025327
P577
1999-09-01T00:00:00Z